{"disease":{"id":"hepatitis-c-chronic","name":"hepatitis c chronic"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03944447","title":"Outcomes Mandate National Integration With Cannabis as Medicine","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":200000,"lead_sponsor_name":"OMNI Medical Services, LLC","has_results":false},{"nct_id":"NCT03200379","title":"Nation-wide Hepatitis C Virus (HCV) Registry in Taiwan","phase":"","overall_status":"RECRUITING","enrollment_count":150000,"lead_sponsor_name":"Kaohsiung Medical University Chung-Ho Memorial Hospital","has_results":false},{"nct_id":"NCT06596213","title":"Hepatitis Inequalities Study","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":100000,"lead_sponsor_name":"Chinese University of Hong Kong","has_results":false},{"nct_id":"NCT03423641","title":"An Observational Study of the Safety of Direct-acting Antivirals in Patients With Hepatitis C","phase":"","overall_status":"COMPLETED","enrollment_count":33808,"lead_sponsor_name":"Kaiser Permanente","has_results":true},{"nct_id":"NCT04943588","title":"Treating Hepatitis C in Pakistan. Strategies to Avoid Resistance to Antiviral Drugs","phase":"","overall_status":"RECRUITING","enrollment_count":25000,"lead_sponsor_name":"Queen Mary University of London","has_results":false},{"nct_id":"NCT01679834","title":"An Observational Study of Pegasys in Dual- or Triple-Therapy in Patients With Chronic Hepatitis C","phase":"","overall_status":"COMPLETED","enrollment_count":7500,"lead_sponsor_name":"Hoffmann-La Roche","has_results":false},{"nct_id":"NCT01457755","title":"Gilead Sustained Virologic Response (SVR) Registry","phase":"","overall_status":"COMPLETED","enrollment_count":6625,"lead_sponsor_name":"Gilead Sciences","has_results":false},{"nct_id":"NCT07137247","title":"Immune Dynamics in the Natural History of Chronic HBV Infection","phase":"","overall_status":"RECRUITING","enrollment_count":5000,"lead_sponsor_name":"Nanfang Hospital, Southern Medical University","has_results":false},{"nct_id":"NCT05813691","title":"Epidemiology of Occult Hepatitis C Virus Infection in Patients Born Before 1969 in the Hospital Setting: a Spontaneous Opportunistic Screening Initiative.","phase":"","overall_status":"UNKNOWN","enrollment_count":4000,"lead_sponsor_name":"Fondazione Policlinico Universitario Agostino Gemelli IRCCS","has_results":false},{"nct_id":"NCT05062967","title":"Evaluation of Orthohepevirus C Infection as an Emerging Cause of Zoonotic Origin Disease","phase":"","overall_status":"UNKNOWN","enrollment_count":3257,"lead_sponsor_name":"Maimónides Biomedical Research Institute of Córdoba","has_results":false},{"nct_id":"NCT04014179","title":"Enhancing Hepatitis C Testing and Treatment Among People Who Inject Drugs Attending Needle and Syringe Programs","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":2700,"lead_sponsor_name":"Kirby Institute","has_results":false},{"nct_id":"NCT06638320","title":"Hepatitis Delta Virus Infection: Cross-sectional Study in Patients With Chronic Hepatitis B Virus Infection","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":2452,"lead_sponsor_name":"Tam Anh Research Institute","has_results":false},{"nct_id":"NCT07298577","title":"Use of Gender, Age, Alfa-fetoprotein (AFP), and Des-gamma-carboxyprothrombin (PIVKA-II) or GAAD Score in Addition to Ultrasound for Surveillance of People At-risk for Developing Hepatocellular Carcinoma in Asia in Order to Detect Early Liver Cancer","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":2100,"lead_sponsor_name":"Siriraj Hospital","has_results":false},{"nct_id":"NCT00689390","title":"Three-year Follow-up of Participants After Administration of Boceprevir or Narlaprevir for the Treatment of Chronic Hepatitis C (P05063)","phase":"PHASE2, PHASE3","overall_status":"TERMINATED","enrollment_count":1954,"lead_sponsor_name":"Merck Sharp & Dohme LLC","has_results":true},{"nct_id":"NCT03513796","title":"Evaluation of Multiple HCV Diagnosis Pathways for Efficacy, Cost Effectiveness and Cure in NHS Tayside","phase":"","overall_status":"COMPLETED","enrollment_count":1949,"lead_sponsor_name":"NHS Tayside","has_results":false},{"nct_id":"NCT00913757","title":"A Study of Molecular and Genetic Factors for Liver Cancer in the Greater Baltimore Area","phase":"","overall_status":"COMPLETED","enrollment_count":1871,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":false},{"nct_id":"NCT03594838","title":"Evaluation of HCV Viremia Testing Approaches Among PWID in Georgia","phase":"NA","overall_status":"COMPLETED","enrollment_count":1672,"lead_sponsor_name":"Foundation for Innovative New Diagnostics, Switzerland","has_results":false},{"nct_id":"NCT01609049","title":"An Observational Study of Peginterferon Alfa-2a in Combination With Ribavirin in Participants With Chronic Hepatitis C and Compensated Liver Cirrhosis","phase":"","overall_status":"COMPLETED","enrollment_count":1496,"lead_sponsor_name":"Hoffmann-La Roche","has_results":false},{"nct_id":"NCT01429792","title":"A Study Evaluating Slow Response/Non-Rapid Response in Patients With Chronic Hepatitis C, Genotype 1, 2, 3 & 4 Treated With Pegasys (Peginterferon Alfa-2a) and Copegus (Ribavirin)","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":1013,"lead_sponsor_name":"Hoffmann-La Roche","has_results":true},{"nct_id":"NCT05401136","title":"Evaluating the Chain of Addiction Care (CAC)","phase":"","overall_status":"UNKNOWN","enrollment_count":1000,"lead_sponsor_name":"Radboud University Medical Center","has_results":false},{"nct_id":"NCT04029246","title":"Re-engaging Patients With Hepatitis C Into Care","phase":"NA","overall_status":"UNKNOWN","enrollment_count":1000,"lead_sponsor_name":"Glasgow Royal Infirmary","has_results":false},{"nct_id":"NCT01604291","title":"An Observational Study of Dual and Triple Therapies Based on Pegasys (Peginterferon Alfa-2a) in Patients With Chronic Hepatitis C","phase":"","overall_status":"COMPLETED","enrollment_count":991,"lead_sponsor_name":"Hoffmann-La Roche","has_results":true},{"nct_id":"NCT03896087","title":"Evaluation of Dried Blood Spot for HCV RNA Testing","phase":"NA","overall_status":"COMPLETED","enrollment_count":942,"lead_sponsor_name":"Foundation for Innovative New Diagnostics, Switzerland","has_results":false},{"nct_id":"NCT06373198","title":"Implementation of a Re-engagement Program for Hepatitis C Patients Lost to Follow-up in Argentina.","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":800,"lead_sponsor_name":"Hospital El Cruce","has_results":false},{"nct_id":"NCT04166266","title":"National Cohort of Patients Co-infected With Hepatitis B and Delta Viruses","phase":"","overall_status":"RECRUITING","enrollment_count":800,"lead_sponsor_name":"ANRS, Emerging Infectious Diseases","has_results":false},{"nct_id":"NCT01544920","title":"Safety and Efficacy of Boceprevir/Peginterferon Alfa-2a/Ribavirin in Interleukin-28B CC Allele-Positive Chronic Hepatitis C Virus (HCV) Genotype 1 Participants (P07755)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":737,"lead_sponsor_name":"Merck Sharp & Dohme LLC","has_results":true},{"nct_id":"NCT01023035","title":"Boceprevir/Peginterferon/Ribavirin for Chronic Hepatitis C: Erythropoietin Use Versus Ribavirin Dose Reduction for Anemia (P06086 AM2)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":687,"lead_sponsor_name":"Merck Sharp & Dohme LLC","has_results":true},{"nct_id":"NCT01508130","title":"An Observational Study of Peginterferon (e.g. Pegasys)-Based Direct Acting Antiviral Triple Therapy in Patients With Chronic Hepatitis C Genotype 1","phase":"","overall_status":"COMPLETED","enrollment_count":672,"lead_sponsor_name":"Hoffmann-La Roche","has_results":true},{"nct_id":"NCT03772002","title":"Hepatitis C Surveillance With Linkage to Care of Patients From Non-ID Departments in Jiangsu","phase":"NA","overall_status":"UNKNOWN","enrollment_count":600,"lead_sponsor_name":"The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School","has_results":false},{"nct_id":"NCT01457768","title":"A Gilead Sequence Registry of Subjects Who Did Not Achieve Sustained Virologic Response","phase":"","overall_status":"COMPLETED","enrollment_count":570,"lead_sponsor_name":"Gilead Sciences","has_results":false},{"nct_id":"NCT01659567","title":"A Study of Predictors of the Effectiveness of Pegylated Interferon in a Cohort of Participants With Hepatitis C","phase":"","overall_status":"COMPLETED","enrollment_count":516,"lead_sponsor_name":"Hoffmann-La Roche","has_results":true},{"nct_id":"NCT03551002","title":"Impact of DAA Uptake in Controlling HCV Epidemic and Modeling Interventions for HCV Elimination Among HIV-infected Persons in San Diego","phase":"","overall_status":"UNKNOWN","enrollment_count":450,"lead_sponsor_name":"University of California, San Diego","has_results":false},{"nct_id":"NCT01392742","title":"An Observational Study on Predictive Factors of Response in Patients With Chronic Hepatitis C Treated With Pegasys (Peginterferon Alfa-2a) and Ribavirin","phase":"","overall_status":"COMPLETED","enrollment_count":443,"lead_sponsor_name":"Hoffmann-La Roche","has_results":true},{"nct_id":"NCT03117569","title":"Trial of Simplified Treatment Monitoring for 8 Weeks Glecaprevir/Pibrentasvir in Chronic Hepatitis C Patients","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":380,"lead_sponsor_name":"Kirby Institute","has_results":true},{"nct_id":"NCT00800748","title":"A Study of Combination Treatment With Peginterferon Alfa-2a (Pegasys) Plus Ribavirin (Copegus) in Participants With Chronic Hepatitis C","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":372,"lead_sponsor_name":"Hoffmann-La Roche","has_results":false},{"nct_id":"NCT03995485","title":"KW-136 With Sofosbuvir for Chinese Adults With Chronic Hepatitis C","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":371,"lead_sponsor_name":"Kawin Technology Share-holding Co., Ltd.","has_results":false},{"nct_id":"NCT01353911","title":"Grazoprevir (MK-5172) Administered With Peginterferon and Ribavirin in Treatment-Naïve Participants With Chronic Hepatitis C (MK-5172-003)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":368,"lead_sponsor_name":"Merck Sharp & Dohme LLC","has_results":true},{"nct_id":"NCT02765490","title":"Efficacy and Safety of Combinations of AL-335, Odalasvir (ODV) and Simeprevir (SMV) in the Treatment of Chronic Hepatitis C Infection","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":365,"lead_sponsor_name":"Janssen Research & Development, LLC","has_results":true},{"nct_id":"NCT03226509","title":"Transforming the Cascade Of Hepatitis C Care","phase":"","overall_status":"COMPLETED","enrollment_count":325,"lead_sponsor_name":"University of Pittsburgh","has_results":false},{"nct_id":"NCT05062408","title":"Impact of the Sustained Viral Response of Chronic Hepatitis c After Treatment With Direct Action Antivirals","phase":"","overall_status":"COMPLETED","enrollment_count":321,"lead_sponsor_name":"Fundación Pública Andaluza para la gestión de la Investigación en Sevilla","has_results":false},{"nct_id":"NCT01939197","title":"A Multipart, Open-label Study to Evaluate the Safety and Efficacy of ABT-450/r/ABT-267 With and Without ABT-333 Coadministered With and Without Ribavirin in Adult With Genotype 1 or 4 Hepatitis C Virus (HCV) Infection and Human Immunodeficiency Virus, Type 1 Coinfection","phase":"PHASE2, PHASE3","overall_status":"COMPLETED","enrollment_count":318,"lead_sponsor_name":"AbbVie","has_results":true},{"nct_id":"NCT05474781","title":"Eliminating HCV Infection Among PWUD","phase":"","overall_status":"UNKNOWN","enrollment_count":300,"lead_sponsor_name":"Vancouver Infectious Diseases Centre","has_results":false},{"nct_id":"NCT07095192","title":"Scaling Up Point-of-Care Hepatitis C Testing and Treatment in Canada","phase":"","overall_status":"RECRUITING","enrollment_count":300,"lead_sponsor_name":"McGill University","has_results":false},{"nct_id":"NCT04310787","title":"Long-term Prognosis of Patients With Hepatitis B Related Acute-on-chronic Liver Failure","phase":"","overall_status":"RECRUITING","enrollment_count":300,"lead_sponsor_name":"Third Affiliated Hospital, Sun Yat-Sen University","has_results":false},{"nct_id":"NCT06658782","title":"Abbreviated Magnetic Resonance Imaging vs Ultrasound Surveillance for Liver Cancer dETection in People at High Risk of Developing Liver Cancer","phase":"","overall_status":"RECRUITING","enrollment_count":300,"lead_sponsor_name":"University of Oxford","has_results":false},{"nct_id":"NCT04952207","title":"Effectiveness and Safety of Direct-Acting Antiviral Agents for the Treatment of Chronic Hepatitis C","phase":"","overall_status":"UNKNOWN","enrollment_count":300,"lead_sponsor_name":"Qing XIe","has_results":false},{"nct_id":"NCT03155906","title":"Integrated Treatment of Hepatitis C Virus Infection","phase":"NA","overall_status":"COMPLETED","enrollment_count":298,"lead_sponsor_name":"Haukeland University Hospital","has_results":false},{"nct_id":"NCT01370642","title":"Vaniprevir Administered With Pegylated-interferon and Ribavirin in Japanese Treatment-Naïve Chronic Hepatitis C Participants (MK-7009-043)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":294,"lead_sponsor_name":"Merck Sharp & Dohme LLC","has_results":true},{"nct_id":"NCT01648140","title":"Dose Ranging of GSK2336805 in Combination Therapy","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":286,"lead_sponsor_name":"GlaxoSmithKline","has_results":true},{"nct_id":"NCT00704405","title":"Safety and Efficacy of Vaniprevir (MK-7009) With Pegylated Interferon (Peg-IFN) and Ribavirin (RBV) in Treatment-Experienced Hepatitis C Virus (HCV) Participants (MK-7009-009)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":285,"lead_sponsor_name":"Merck Sharp & Dohme LLC","has_results":true}],"total":50},"guidelines":[],"source":"Drug Landscape verified database"}